Prostate-specific Antigen (PSA) Testing Market, Global Outlook and Forecast 2023-2028

Report ID: 1371490 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Prostate-specific Antigen (PSA) Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Prostate-specific Antigen (PSA) Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prostate-specific Antigen (PSA) Testing Overall Market Size
    2.1 Global Prostate-specific Antigen (PSA) Testing Market Size: 2021 VS 2028
    2.2 Global Prostate-specific Antigen (PSA) Testing Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Prostate-specific Antigen (PSA) Testing Players in Global Market
    3.2 Top Global Prostate-specific Antigen (PSA) Testing Companies Ranked by Revenue
    3.3 Global Prostate-specific Antigen (PSA) Testing Revenue by Companies
    3.4 Top 3 and Top 5 Prostate-specific Antigen (PSA) Testing Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Prostate-specific Antigen (PSA) Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Prostate-specific Antigen (PSA) Testing Players in Global Market
        3.6.1 List of Global Tier 1 Prostate-specific Antigen (PSA) Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Prostate-specific Antigen (PSA) Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Prostate-specific Antigen (PSA) Testing Market Size Markets, 2021 & 2028
        4.1.2 CLIA Method
        4.1.3 ELISA Method
    4.2 By Type - Global Prostate-specific Antigen (PSA) Testing Revenue & Forecasts
        4.2.1 By Type - Global Prostate-specific Antigen (PSA) Testing Revenue, 2017-2022
        4.2.2 By Type - Global Prostate-specific Antigen (PSA) Testing Revenue, 2023-2028
        4.2.3 By Type - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Prostate-specific Antigen (PSA) Testing Market Size, 2021 & 2028
        5.1.2 Screening
        5.1.3 Post-treatment Monitoring
        5.1.4 Other
    5.2 By Application - Global Prostate-specific Antigen (PSA) Testing Revenue & Forecasts
        5.2.1 By Application - Global Prostate-specific Antigen (PSA) Testing Revenue, 2017-2022
        5.2.2 By Application - Global Prostate-specific Antigen (PSA) Testing Revenue, 2023-2028
        5.2.3 By Application - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Prostate-specific Antigen (PSA) Testing Market Size, 2021 & 2028
    6.2 By Region - Global Prostate-specific Antigen (PSA) Testing Revenue & Forecasts
        6.2.1 By Region - Global Prostate-specific Antigen (PSA) Testing Revenue, 2017-2022
        6.2.2 By Region - Global Prostate-specific Antigen (PSA) Testing Revenue, 2023-2028
        6.2.3 By Region - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028
        6.3.2 US Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.3.3 Canada Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.3.4 Mexico Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028
        6.4.2 Germany Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.3 France Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.4 U.K. Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.5 Italy Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.6 Russia Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.7 Nordic Countries Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.4.8 Benelux Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028
        6.5.2 China Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.5.3 Japan Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.5.4 South Korea Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.5.5 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.5.6 India Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028
        6.6.2 Brazil Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.6.3 Argentina Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028
        6.7.2 Turkey Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.7.3 Israel Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.7.4 Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
        6.7.5 UAE Prostate-specific Antigen (PSA) Testing Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.1.4 Abbott Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Boston Scientific Corporation
        7.2.1 Boston Scientific Corporation Corporate Summary
        7.2.2 Boston Scientific Corporation Business Overview
        7.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.2.4 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.2.5 Boston Scientific Corporation Key News
    7.3 Bayer AG
        7.3.1 Bayer AG Corporate Summary
        7.3.2 Bayer AG Business Overview
        7.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.3.4 Bayer AG Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.3.5 Bayer AG Key News
    7.4 Siemens Healthcare
        7.4.1 Siemens Healthcare Corporate Summary
        7.4.2 Siemens Healthcare Business Overview
        7.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.4.4 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.4.5 Siemens Healthcare Key News
    7.5 DiaSorin
        7.5.1 DiaSorin Corporate Summary
        7.5.2 DiaSorin Business Overview
        7.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.5.4 DiaSorin Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.5.5 DiaSorin Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.6.4 Roche Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 Beckman Coulter
        7.7.1 Beckman Coulter Corporate Summary
        7.7.2 Beckman Coulter Business Overview
        7.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.7.4 Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.7.5 Beckman Coulter Key News
    7.8 PerkinElmer
        7.8.1 PerkinElmer Corporate Summary
        7.8.2 PerkinElmer Business Overview
        7.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.8.4 PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.8.5 PerkinElmer Key News
    7.9 Tosoh
        7.9.1 Tosoh Corporate Summary
        7.9.2 Tosoh Business Overview
        7.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.9.4 Tosoh Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.9.5 Tosoh Key News
    7.10 Ortho Clinical
        7.10.1 Ortho Clinical Corporate Summary
        7.10.2 Ortho Clinical Business Overview
        7.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.10.4 Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.10.5 Ortho Clinical Key News
    7.11 Fujirebio
        7.11.1 Fujirebio Corporate Summary
        7.11.2 Fujirebio Business Overview
        7.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.11.4 Fujirebio Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.11.5 Fujirebio Key News
    7.12 Mediwatch
        7.12.1 Mediwatch Corporate Summary
        7.12.2 Mediwatch Business Overview
        7.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.12.4 Mediwatch Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.12.5 Mediwatch Key News
    7.13 BodiTech
        7.13.1 BodiTech Corporate Summary
        7.13.2 BodiTech Business Overview
        7.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.13.4 BodiTech Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.13.5 BodiTech Key News
    7.14 Bristol-Myers Squibb Company
        7.14.1 Bristol-Myers Squibb Company Corporate Summary
        7.14.2 Bristol-Myers Squibb Company Business Overview
        7.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.14.4 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.14.5 Bristol-Myers Squibb Company Key News
    7.15 GE Healthcare
        7.15.1 GE Healthcare Corporate Summary
        7.15.2 GE Healthcare Business Overview
        7.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.15.4 GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.15.5 GE Healthcare Key News
    7.16 Endocare
        7.16.1 Endocare Corporate Summary
        7.16.2 Endocare Business Overview
        7.16.3 Endocare Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.16.4 Endocare Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.16.5 Endocare Key News
    7.17 Merck＆Co.
        7.17.1 Merck＆Co. Corporate Summary
        7.17.2 Merck＆Co. Business Overview
        7.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.17.4 Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.17.5 Merck＆Co. Key News
    7.18 Medtronic
        7.18.1 Medtronic Corporate Summary
        7.18.2 Medtronic Business Overview
        7.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.18.4 Medtronic Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.18.5 Medtronic Key News
    7.19 Sanofi-Aventis SA
        7.19.1 Sanofi-Aventis SA Corporate Summary
        7.19.2 Sanofi-Aventis SA Business Overview
        7.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Major Product Offerings
        7.19.4 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
        7.19.5 Sanofi-Aventis SA Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Prostate-specific Antigen (PSA) Testing Market Opportunities & Trends in Global Market
    Table 2. Prostate-specific Antigen (PSA) Testing Market Drivers in Global Market
    Table 3. Prostate-specific Antigen (PSA) Testing Market Restraints in Global Market
    Table 4. Key Players of Prostate-specific Antigen (PSA) Testing in Global Market
    Table 5. Top Prostate-specific Antigen (PSA) Testing Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Prostate-specific Antigen (PSA) Testing Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Prostate-specific Antigen (PSA) Testing Product Type
    Table 9. List of Global Tier 1 Prostate-specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Prostate-specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Prostate-specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Prostate-specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Prostate-specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Prostate-specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 32. Abbott Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 33. Boston Scientific Corporation Corporate Summary
    Table 34. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 35. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 36. Bayer AG Corporate Summary
    Table 37. Bayer AG Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 38. Bayer AG Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 39. Siemens Healthcare Corporate Summary
    Table 40. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 41. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 42. DiaSorin Corporate Summary
    Table 43. DiaSorin Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 44. DiaSorin Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 47. Roche Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 48. Beckman Coulter Corporate Summary
    Table 49. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 50. Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 51. PerkinElmer Corporate Summary
    Table 52. PerkinElmer Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 53. PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 54. Tosoh Corporate Summary
    Table 55. Tosoh Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 56. Tosoh Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 57. Ortho Clinical Corporate Summary
    Table 58. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 59. Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 60. Fujirebio Corporate Summary
    Table 61. Fujirebio Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 62. Fujirebio Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 63. Mediwatch Corporate Summary
    Table 64. Mediwatch Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 65. Mediwatch Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 66. BodiTech Corporate Summary
    Table 67. BodiTech Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 68. BodiTech Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 69. Bristol-Myers Squibb Company Corporate Summary
    Table 70. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 71. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 72. GE Healthcare Corporate Summary
    Table 73. GE Healthcare Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 74. GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 75. Endocare Corporate Summary
    Table 76. Endocare Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 77. Endocare Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 78. Merck＆Co. Corporate Summary
    Table 79. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 80. Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 81. Medtronic Corporate Summary
    Table 82. Medtronic Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 83. Medtronic Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
    Table 84. Sanofi-Aventis SA Corporate Summary
    Table 85. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Offerings
    Table 86. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Prostate-specific Antigen (PSA) Testing Segment by Type in 2021
    Figure 2. Prostate-specific Antigen (PSA) Testing Segment by Application in 2021
    Figure 3. Global Prostate-specific Antigen (PSA) Testing Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Prostate-specific Antigen (PSA) Testing Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2021
    Figure 8. By Type - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 12. US Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 16. Germany Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 17. France Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 24. China Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 28. India Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 30. Brazil Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
    Figure 33. Turkey Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Prostate-specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bayer AG Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. DiaSorin Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Tosoh Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Fujirebio Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Mediwatch Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. BodiTech Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Endocare Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Medtronic Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
108
Frequently Asked Questions
Prostate-specific Antigen Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate-specific Antigen Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate-specific Antigen Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports